Report overview
Cancer Supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects.?
This report aims to provide a comprehensive presentation of the global market for Cancer Supportive Care Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Supportive Care Drugs. This report contains market size and forecasts of Cancer Supportive Care Drugs in global, including the following market information:
Global Cancer Supportive Care Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Supportive Care Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Granulocyte-Colony Stimulating Factors (G-CSFS) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Supportive Care Drugs include Amgen, Johnson & Johnson, Novartis, Baxter International, Fagron Group, Teva Pharmaceuticals Industries, F.Hoffmann La-Roche Ltd, Apr Applied Pharma Science Research and Acacia Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Supportive Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Supportive Care Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Supportive Care Drugs Market Segment Percentages, by Type, 2022 (%)
Granulocyte-Colony Stimulating Factors (G-CSFS)
Erythropoietin-Stimulating Agents (ESAS)
Antiemetics
Bisphosphonates
Opioids
Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
Others
Global Cancer Supportive Care Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Supportive Care Drugs Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others
Global Cancer Supportive Care Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Supportive Care Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Supportive Care Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Supportive Care Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Johnson & Johnson
Novartis
Baxter International
Fagron Group
Teva Pharmaceuticals Industries
F.Hoffmann La-Roche Ltd
Apr Applied Pharma Science Research
Acacia Pharma
Kyowa Hakko Kirin
Helsinn Healthcare
Heron Pharma
Merck & Co. Inc
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Supportive Care Drugs, market overview.
Chapter 2: Global Cancer Supportive Care Drugs market size in revenue.
Chapter 3: Detailed analysis of Cancer Supportive Care Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Supportive Care Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
